Skip to content
10-Q

Quarterly Report

OCUGEN, INC. OCGN

0001628280-26-032454

← back to feed
Filed
May 8, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 338.52M sh
Shares Diluted Q1 2026 · Mar 31, 2026 327.54M sh
Shares Diluted Q1 2026 · Mar 31, 2025 292M sh
Capex Q1 2026 · Mar 31, 2026 $6K
Capex Q1 2026 · Mar 31, 2025 $16K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$21.79M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$19.36M
Long Term Debt Q1 2026 · Mar 31, 2026 $24.19M
Long Term Debt Q1 2026 · Dec 31, 2025 $27.54M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $31.9M
Stockholders Equity Q1 2026 · Mar 31, 2026 $5.81M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$12.17M
Stockholders Equity Q1 2026 · Mar 31, 2025 $15.91M
Stockholders Equity Q1 2026 · Dec 31, 2024 $29.63M
Current Liabilities Q1 2026 · Mar 31, 2026 $20.71M
Current Liabilities Q1 2026 · Dec 31, 2025 $23.04M
Total Liabilities Q1 2026 · Mar 31, 2026 $51.1M
Total Liabilities Q1 2026 · Dec 31, 2025 $55.68M
Current Assets Q1 2026 · Mar 31, 2026 $38.55M
Current Assets Q1 2026 · Dec 31, 2025 $24.34M
Total Assets Q1 2026 · Mar 31, 2026 $56.91M
Total Assets Q1 2026 · Dec 31, 2025 $43.52M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.06
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.05
Eps Basic Q1 2026 · Mar 31, 2026 −$0.06
Eps Basic Q1 2026 · Mar 31, 2025 −$0.05
Sga Expense Q1 2026 · Mar 31, 2026 $8.12M
Sga Expense Q1 2026 · Mar 31, 2025 $6.45M
Rd Expense Q1 2026 · Mar 31, 2026 $11.26M
Rd Expense Q1 2026 · Mar 31, 2025 $9.53M
Net Income Q1 2026 · Mar 31, 2026 −$19.18M
Net Income Q1 2026 · Mar 31, 2025 −$15.35M
Operating Income Q1 2026 · Mar 31, 2026 −$17.84M
Operating Income Q1 2026 · Mar 31, 2025 −$14.5M
Revenue Q1 2026 · Mar 31, 2026 $1.53M
Revenue Q1 2026 · Mar 31, 2025 $1.48M